Gene expression profiles of peripheral and cord blood mononuclear cells altered by thymic stromal lymphopoietin

Pediatric Research

Volumn 57, Issue 4, 2005, Pages 563-569

  Urashima, Mitsuyoshi ^a   Sakuma, Mio ^a   Teramoto, Satoshi ^a   Fuyama, Yuichi ^a   Eto, Yoshikatsu ^a   Kondo, Kazuhiro ^a   Tanaka, Tadao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; PROTEASOME; THYMIC STROMAL LYMPHOPOIETIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNITY; MALE; MONONUCLEAR CELL; NORMAL HUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

ADULT; ANIMALS; ANTIGENS, CD40; CELLS, CULTURED; CHEMOKINES; CYTOKINES; FEMALE; FETAL BLOOD; GENE EXPRESSION PROFILING; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; MACROPHAGES; MALE; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRYPTOPHAN OXYGENASE;

EID: 15244339842     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000155759.29448.13     Document Type: Article

References (49)

1. Busse WW, Lemanske RF Jr 2001 Asthma. N Engl J Med 344:350-362
2. Zuany-Amorim C, Sawicka E, Manlius C, Le Moine A, Brunet LR, Kemeny DM, Bowen G, Rook G, Walker C 2002 Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 8:625-629
3. Forsthuber T, Yip HC, Lehmann PV 1996 Induction of TH1 and TH2 immunity in neonatal mice. Science 271:1728-1730
4. Behrman RE, Kliegman RM, Jenson HB 2003 Nelson Textbook of Pediatrics. Elsevier Science, Philadelphia, pp 743-747
5. Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS 1996 Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88:795-802
6. Levin SD, Koelling RM, Friend SL, Isaksen DE, Ziegler SF, Perlmutter RM, Farr AG 1999 Thymic stromal lymphopoietin: a cytokine that promotes the development of IgM+ B cells in vitro and signals via a novel mechanism. J Immunol 162:677-683
7. Sims JE, Williams DE, Morrissey PJ, Garka K, Foxworthe D, Price V, Friend SL, Farr A, Bedell MA, Jenkins NA, Copeland NG, Grabstein K, Paxton RJ 2000 Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med 192:671-680
8. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd, Bazan F, Kastelein RA, Liu YJ 2002 Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673-680
9. Gilliet M, Soumelis V, Watanabe N, Hanabuchi S, Antonenko S, Waal-Malefyt Rd, Liu YJ 2003 Human dendritic cells activated by TSLP and CD40L induce proallergic cytotoxic T cells. J Exp Med 197:1059-1063
10. Schena M, Shalon D, Davis RW, Brown PO 1995 Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270:467-470
11. Chtanova T, Kemp RA, Sutherland AP, Ronchese F, Mackay CR 2001 Gene microarrays reveal extensive differential gene expression in both CD4(+) and CD8(+) type 1 and type 2 T cells. J Immunol 167:3057-3063
12. Hamalainen H, Zhou H, Chou W, Hashizume H, Heller R, Lahesmaa R 2001 Distinct gene expression profiles of human type 1 and type 2 T helper cells. Genome Biol 2:RESEARCH0022
13. Hashimoto S, Nagai S, Sese J, Suzuki T, Obata A, Sato T, Toyoda N, Dong HY, Kurachi M, Nagahata T, Shizuno K, Morishita S, Matsushima K 2003 Gene expression profile in human leukocytes. Blood 101:3509-3513
14. Zelenika D, Adams E, Humm S, Graca L, Thompson S, Cobbold SP, Waldmann H 2002 Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 168:1069-1079
15. Ishibashi Y, Hanyu N, Nakada K, Suzuki Y, Yamamoto T, Yanaga K, Ohkawa K, Hashimoto N, Nakajima T, Saito H, Matsushima M, Urashima M 2003 Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma. Cancer Res 63:5159-5164
16. Widner B, Werner ER, Schennach H, Fuchs D 1999 An HPLC method to determine tryptophan and kynurenine in serum simultaneously. Adv Exp Med Biol 467:827-832
17. Eisen MB, Spellman PT, Brown PO, Botstein D 1998 Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
18. Mellor AL, Munn DH 1999 Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? Immunol Today 20:469-473
19. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, Slingluff CL Jr, Mellor AL 2002 Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297:1867-1870
20. Gong F, Yanofsky C 2001 Reproducing tna operon regulation in vitro in an S-30 system. Tryptophan induction inhibits cleavage of TnaC peptidyl-tRNA. J Biol Chem 276:1974-1983
21. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL 1999 Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med 189:1363-1372
22. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB 2002 Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med 196:459-468
23. Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, Opelz G 2002 Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 196:447-457
24. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL 1998 Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281:1191-1193
25. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH 2001 Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2:64-68
26. Friberg M, Jennings R, Alsarraj M, Dessureault S, Cantor A, Extermann M, Mellor AL, Munn DH, Antonia SJ 2002 Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell-mediated rejection. Int J Cancer 101:151-155
27. Uyttenhove C, Pilotte L, Theate I, Stroobant V, Colau D, Parmentier N, Boon T, Van Den Eynde BJ 2003 Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9:1269-1274
28. Osborn MJ, Ryan PL, Kirchhof N, Panoskaltsis-Mortari A, Mortari F, Tudor KS 2004 Overexpression of murine TSLP impairs lymphopoiesis and myelopoiesis. Blood 103:843-851
29. Muhlfeld AS, Segerer S, Hudkins K, Farr AG, Bao L, Kraus D, Holers VM, Quigg RJ, Alpers CE 2004 Overexpression of complement inhibitor Crry does not prevent cryoglobulin-associated membranoproliferative glomerulonephritis. Kidney Int 65:1214-1223
30. Kuwashima N, Kageyama S, Eto Y, Urashima M 2001 CD40 ligand immunotherapy in cancer: an efficient approach. Leuk Lymphoma 42:1367-1377
31. MacKenzie CR, Hadding U, Daubener W 1998 Interferon-gamma-induced activation of indoleamine 2,3-dioxygenase in cord blood monocyte-derived macrophages inhibits the growth of group B streptococci. J Infect Dis 178:875-878
32. Hunt DW, Huppertz HI, Jiang HJ, Petty RE 1994 Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 184:4333-4343
33. Urashima M, Hoshi Y, Shishikura A, Kamijo M, Kato Y, Akatsuka J, Maekawa K 1994 Umbilical cord blood as a rich source of immature hematopoietic stem cells. Acta Paediatr Jpn 36:649-655
34. Schapira AH 2004 Disease modification in Parkinson's disease. Lancet Neurol 3:362-368
35. Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK 2003 RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev 67:657-685
36. Weller RO, Nicoll JA 2003 Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 25:611-616
37. Urashima M, Hoshi Y, Akiyama M, Kamijo M, Shishikura A, Kato Y, Akatsuka J, Maekawa K 1995 Effects of cytokines on hematopoietic progenitor cells in cord blood, in bone marrow, and in peripheral blood mobilized by chemotherapy and G-CSF. Acta Paediatr Jpn 37:21-26
38. Gardiner CM, Meara AO, Reen DJ 1998 Differential cytotoxicity of cord blood and bone marrow-derived natural killer cells. Blood 91:207-213
39. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA 2001 Possible new role for NF-κB in the resolution of inflammation. Nat Med 7:1291-1297
40. Shumway SD, Miyamoto S 2004 A mechanistic insight into a proteasome-independent constitutive inhibitor κBα (IκBα) degradation and nuclear-factor κB (NF-κB) activation pathway in WEHI-231 B-cells. Biochem J 380:173-180
41. Gerard C, Rollins BJ 2001 Chemokines and disease. Nat Immunol 2:108-115
42. Luther SA, Cyster JG 2001 Chemokines as regulators of T cell differentiation. Nat Immunol 2:102-107
43. Mackay CR 2001 Chemokines: immunology's high impact factors. Nat Immunol 2:95-101
44. Heil M, Ziegelhoeffer T, Wagner S, Fernandez B, Helisch A, Martin S, Tribulova S, Kuziel WA, Bachmann G, Schaper W 2004 Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 94:671-677
45. Barlic J, Sechler JM, Murphy PM 2003 IL-15 and IL-2 oppositely regulate expression of the chemokine receptor CX3CR1. Blood 102:3494-3503
46. Kasper B, Brandt E, Bulfone-Paus S, Petersen F 2004 Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood 103:1602-1610
47. Schenk BI, Petersen F, Flad HD, Brandt E 2002 Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J Immunol 169:2602-2610
48. Rose CE Jr, Sung SS, Fu SM 2003 Significant involvement of CCL2 (MCP-1) in inflammatory disorders of the lung. Microcirculation 10:273-288
49. Christen U, McGavern DB, Luster AD, von Herrath MG, Oldstone MB 2003 Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease. J Immunol 171:6838-6845